Humana Inc. (NYSE: HUM) has reported E.P.S. of $-5.76 for its fourth fiscal quarter (ending December 31) versus $-4.42 for the same period a year ago. This performance was $-3.64 short of the consensus estimate of $-2.12. E.P.S. were $10.01 for the latest four quarters through December 31 versus $20.09 for the same period a year ago — a decline of -50%.
Recent Price Action
On 2/11/25, Humana Inc. (NYSE: HUM) stock declined by -3.5%, closing at $257.34. Moreover, this decline was accompanied by exceptionally high trading volume at 260% of normal. Relative to the market the stock has been extremely weak over the last nine months and has declined -12.2% during the last week.
Current PriceTarget Research Rating
Humana has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Humana has a neutral Appreciation Score of 58 but a very low Power Rating of 12, leading to the Negative Value Trend Rating.
Rating Review
In light of this new information and negative market action we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment